AxoGen Inc
NASDAQ:AXGN
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
US |
AxoGen Inc
NASDAQ:AXGN
|
256.9m USD | -27.1 | ||
US |
Abbott Laboratories
NYSE:ABT
|
182.2B USD | 26.4 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.2B USD | 76.1 | ||
US |
Stryker Corp
NYSE:SYK
|
126.5B USD | 38.6 | ||
IE |
Medtronic PLC
NYSE:MDT
|
109.4B USD | 19.4 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
108.5B USD | 46.1 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.1B USD | 23.4 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.5B EUR | 28.8 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 55.9 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
367.2B CNY | 26.3 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
51.5B USD | 63.7 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.